Vehicle-to-grid left the pilot stage in 2026: GM activated bidirectional charging and E3's study for GM Energy values V2G integration at $7 billion by 2030. Nissan, Enel and Nuvve run the first fully commercial V2G hub in Denmark, and AI-managed aggregation is where the margin forms.
The Coimbra startup monitors 600+ satellites and just raised €15.6M (8M) to add radar, build out the NeuraspaceDEF defence platform, and push its AI toward autonomous orbit management. 350%+ revenue growth and a European ministry mandate make the round worth a look.
Vitestro's Aletta became the first CE-marked autonomous phlebotomy device, drawing blood alone in a Danish clinic in June with a 94.5% first-stick rate across 1,633 Dutch trial patients. It excludes the hard cases, waits on the US FDA, and now sits at the center of DARPA's field-transfusion plans.
KaloCyte's ErythroMer is a freeze-dried artificial red blood cell that needs no refrigeration and works for any blood type. DARPA has put $46 million behind it and targets FDA authorization by 2029. The engineering, the $7 billion market, and what killed every substitute before it.
Velaura AI, the chip designer formerly known as Auradine, closed a $110M Series A valuing the company above $1B. Its Titan Core silicon IP claims a 2-4x performance-per-watt gain for AI accelerators, backed by more than 30 million shipped ASICs. Three scenarios through mid-2027.
X-energy received formal notification of up to $1 billion in additional DOE ARDP funding for its first industrial-scale advanced reactor project. The four-unit Xe-100 plant at Dow’s Seadrift site will supply both electricity and high-temperature process steam.
The two operators pooled the world's largest block of D2D spectrum into a neutral host carriers lease instead of owning. In August it reached initial constellation procurement: 2,800 LEO satellites, $600M in early capital, Rocket Lab as likely bus maker. The tower-company math, in numbers.
Isaiah Taylor dropped out of high school at sixteen. Twenty-seven now, he runs the startup Sequoia just valued at $6 billion for a bet on manufacturing nuclear reactors instead of building them.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
